Quoin Net Income from 2010 to 2024
| QNRX Stock | USD 0.62 0.01 1.59% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -8.7 M | Current Value -8.3 M | Quarterly Volatility 11 M |
Check Quoin Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quoin Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 4 M, Total Revenue of 0.0 or Other Operating Expenses of 7 M, as well as many indicators such as Dividend Yield of 7.58, Ptb Ratio of 0.74 or Book Value Per Share of 5.97. Quoin financial statements analysis is a perfect complement when working with Quoin Pharmaceuticals Valuation or Volatility modules.
Quoin | Net Income |
Latest Quoin Pharmaceuticals' Net Income Growth Pattern
Below is the plot of the Net Income of Quoin Pharmaceuticals Ltd over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Quoin Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Quoin Pharmaceuticals Ltd operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Quoin Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quoin Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (8.69 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Quoin Net Income Regression Statistics
| Arithmetic Mean | 6,309,907 | |
| Geometric Mean | 9,523,231 | |
| Coefficient Of Variation | 174.17 | |
| Mean Deviation | 10,122,511 | |
| Median | 15,317,000 | |
| Standard Deviation | 10,989,837 | |
| Sample Variance | 120.8T | |
| Range | 24.6M | |
| R-Value | (0.89) | |
| Mean Square Error | 27.1T | |
| R-Squared | 0.79 | |
| Slope | (2,186,854) | |
| Total Sum of Squares | 1690.9T |
Quoin Net Income History
Other Fundumenentals of Quoin Pharmaceuticals
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Quoin Pharmaceuticals Net Income component correlations
About Quoin Pharmaceuticals Financial Statements
Quoin Pharmaceuticals investors use historical fundamental indicators, such as Quoin Pharmaceuticals' Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quoin Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -8.7 M | -9.1 M | |
| Net Loss | -8.6 M | -9.1 M | |
| Net Loss | -8.5 M | -8.9 M | |
| Net Loss | (9.64) | (9.16) | |
| Net Income Per E B T | 0.89 | 0.59 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.